Discover 1,474 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,474
School-based Paraeducator Education for Engagement at Recess
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Seattle WA, San Francisco CA, Los Angeles CA, Orange CA,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06001788
Phase 1, Recruiting
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
for
Diabetic Kidney Disease, Type 1 Diabetes
Location: Seattle WA, Spokane WA, Aurora CO, Toronto
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT05822609
Phase 2, Recruiting
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
for
Heart Failure, Left Ventricular Systolic Dysfunction
Location: Seattle WA, Edmonton, Palo Alto CA, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT05714085
Phase 2, Phase 3, Recruiting
Building Research for Intervention Development in Gliosis and Eating Habits
for
Gliosis, Child Obesity, Eating
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 9+
Code: NCT06870578
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
for
Diabetes Mellitus, Type 1
Location: Seattle WA, Louisville KY, Philadelphia PA
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 18 - 65
Code: NCT06880835
Recruiting
Ensuring Access to Optimal Therapy in CF: The ENACT Study
for
Cystic Fibrosis (CF)
Location: Seattle WA, Little Rock AR, Birmingham AL
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 3+
Code: NCT07148739
Recruiting
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
for
Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2,
Location: Seattle WA, San Francisco CA, Los Angeles CA, Dallas TX,
Sponsor: Lauren Moore
Sex: All
Age: 6+
Code: NCT01060371
Recruiting
QT-Digital Mental Health Engagement Study
for
Engagement, Patient
Location: Seattle WA, Alexandria VA
Sponsor: University of Washington
Sex: All
Age: 14+
Code: NCT07278765
Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Seattle WA, San Francisco CA, Los Angeles CA, Denver CO,
Sponsor: David Chu
Sex: All
Age: 5+
Code: NCT07390318
Recruiting
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
for
Head and Neck Squamous Cell Carcinoma,
Location: Bremerton WA, Weston WI
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT02734537
Phase 2, Recruiting
Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
for
End Stage Kidney Disease
Location: Seattle WA, San Dimas CA, Houston TX, Knoxville TN,
Sponsor: Diality Inc.
Sex: All
Age: 18 - 70+
Code: NCT06613568
Recruiting
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
for
Colorectal Cancer
Location: Seattle WA, Portland OR, Duarte CA, Aurora CO,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07525206
Phase 3, Recruiting
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
for
Low-grade Glioma, Advanced Solid Tumor
Location: Seattle WA, San Francisco CA, Salt Lake City UT,
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All
Age: 0 - 25
Code: NCT04775485
Phase 2, Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)